SP110
protein-codingSP110 nuclear body protein, the group of PHD finger proteins|Minor histocompatibility antigens|Bromodomain containing
Gene summary
The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]
- IFI41
- IFI75
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~60.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009338
Submitter: ClinGen
SP110 was first reported in relation to autosomal recessive hepatic veno-occlusive disease-immunodeficiency syndrome (VODI) in 2006 (Rosicioli et al., PMID: 16648851). VODI is characterized by bacterial infections (including Pneumocystis jirovecii, cytomegalovirus, enterovirus, or mucocutaneous candidiasis), hepatomegaly or hepatic failure, liver biopsy results consistent with sinusoidal obstruction syndrome, hypogammaglobulinemia, low intracellular cytokine production, and usually T-cell immunodeficiency with normal circulating T and B cell counts. Some patients displayed a complex neurological phenotype, however the association with SP110 is not fully understood (PMID: 23448538). The mechanism of pathogenicity appears to be homozygous loss of function. The curation of SP110 related to autosomal recessive VODI includes both case-level and experimental evidence. Seven variants (missense, frameshift, and nonsense) reported in seven probands in four publications (PMIDs: 16648851, 22621957, 23448538, 32395362) are included in this curation. The heterozygous parents of probands were all unaffected. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is also supported by its enhanced expression in lymphoid tissue (PMID: 16127175), disruption of which is observed by flow cytometry of patient T cell blasts (PMID: 28825155). Additionally, functional alteration is reported in patient cells (PMID: 22621957), such that there is an impairment of B cells to produce IgM, IgG, and IgA. The impaired survival and activation of B cells in vitro most likely explains the hypogammaglobulinemia that is typical of patients with VODI. In summary, there is definitive evidence supporting the relationship between SP110 and autosomal recessive hepatic veno-occlusive disease-immunodeficiency syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0009338
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009338
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009338
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009338
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Cardiovascular; Gastrointestinal; Neurologic
Intervention: Allergy/Immunology/Infectious
Rationale: Mortality is high if the condition is unrecognized; interventions include intravenous immunoglobulin and infectious prophylaxis (Pneumocystis jerovici)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SP110 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_080424.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 116 | 3 | 125 | ||
| missense | 1 | 237 | 24 | 3 | 265 | |
| nonsense | 4 | 10 | 2 | 1 | 17 | |
| start loss | 1 | 1 | ||||
| frameshift | 16 | 5 | 3 | 24 | ||
| splice donor/acceptor (+/-2bp) | 10 | 8 | 18 | |||
| Total | 21 | 25 | 257 | 141 | 6 | 450 |
Highest pathogenic variant AF is 0.000114628165
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_536349.3 | 18 | MANE Select | |
| Ensembl | ENSP00000258381.6 | 18 | MANE Select | |
| RefSeq | NP_001171944.1 | 15 | Standard | |
| RefSeq | NP_001365371.1 | 19 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of transcription by RNA polymerase II
- viral process
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- metal ion binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000258381
- Coding exons
- 18
- Length
- 58436
- Individuals with no LoFs
- 125659
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 89
- Defined
- 125748
- p
- 0.000354
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.335 | 355 | 373 | 0.951 | 0.0000208 | 4695 |
| Missense (PolyPhen) | 24 | 23.936 | 1.0027 | 232 | ||
| Synonymous | -0.121 | 141 | 139 | 1.01 | 0.00000863 | 1307 |
| Loss of Function | 1.83 | 28 | 40.6 | 0.689 | 0.00000221 | 493 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00022 | 0.00022 | rare |
| South Asian | 0.0016 | 0.0016 | notable |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription factor. May be a nuclear hormone receptor coactivator. Enhances transcription of genes with retinoic acid response elements (RARE).;
- Disease
- DISEASE: Hepatic venoocclusive disease with immunodeficiency (VODI) [MIM:235550]: Autosomal recessive primary immunodeficiency associated with hepatic vascular occlusion and fibrosis. The immunodeficiency is characterized by severe hypogammaglobulinemia, combined T and B-cell immunodeficiency, absent lymph node germinal centers, and absent tissue plasma cells. {ECO:0000269|PubMed:16648851}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.496
- RVIS EVS
- 0.54
- RVIS percentile EVS
- 81.1
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.682
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |